Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing

被引:10
|
作者
Fang, Li [1 ]
Monteys, Alex Mas [1 ]
Durr, Alexandra [2 ]
Keiser, Megan [1 ]
Cheng, Congsheng [1 ]
Harapanahalli, Akhil [1 ]
Gonzalez-Alegre, Pedro [1 ,3 ,4 ,5 ]
Davidson, Beverly L. [1 ,6 ]
Wang, Kai [1 ,6 ]
机构
[1] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA
[2] Sorbonne Univ, Univ Hosp Pitie Salpetriere, AP HP, INSERM,CNRS,Paris Brain Inst, Paris, France
[3] Univ Penn, Huntingtons Dis Ctr, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Neurol, Div Movement Disorders, Philadelphia, PA 19104 USA
[5] Spk Therapeut, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源
HUMAN GENETICS AND GENOMICS ADVANCES | 2023年 / 4卷 / 01期
关键词
MUTANT HUNTINGTIN; CCG REPEATS; CAG REPEAT; DISEASE; NEUROPATHOLOGY; REVERSAL; MOTOR;
D O I
10.1016/j.xhgg.2022.100146
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by CAG trinucleotide repeat expansions in exon-1 of huntingtin (HTT). Currently, there is no cure for HD, and the clinical care of individuals with HD is focused on symptom man-agement. Previously, we showed allele-specific deletion of the expanded HTT allele (mHTT) using CRISPR-Cas9 by targeting nearby (<10 kb) SNPs that created or eliminated a protospacer adjacent motif (PAM) near exon-1. Here, we comprehensively analyzed all potential PAM sites within a 10.4-kb genomic region flanking exon-1 of HTT in 983 individuals with HD using a multiplex targeted long-read sequencing approach on the Oxford Nanopore platform. We developed computational tools (NanoBinner and NanoRepeat) to de-multiplex the data, detect repeats, and phase the reads on the expanded or the wild-type HTT allele. One SNP com-mon to 30% of individuals with HD of European ancestry emerged through this analysis, which was confirmed as a strong candidate for allele-specific deletion of the mHTT in human HD cell lines. In addition, up to 57% HD individuals may be candidates for allele-specific editing through combinatorial SNP targeting. Cumulatively, we provide a haplotype map of the region surrounding exon-1 of HTT in individuals affected with HD. Our workflow can be applied to other repeat expansion diseases to facilitate the design of guide RNAs for allele-specific gene editing.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Allele-Specific gene editing approach for a dominant form of Epidermolysis Bullosa Simplex
    Cattaneo, C.
    Latella, M. C.
    Enzo, E.
    De Rosa, L.
    De Luca, M.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A145 - A145
  • [22] Characterisation of the novel HLA-B35:593 allele using short and long-read sequencing technologies
    Secco, Danielle
    Santos, Angela
    Cunha, Mayara
    Vianna, Romulo
    Porto, Luis Cristovao
    HLA, 2024, 103 (05)
  • [23] Characterisation of the novel HLA-C*15:274 allele using short and long-read sequencing technologies
    Oliveira, Victoria
    Andrade, Gabriela
    Porto, Luis Cristovao
    Vianna, Romulo
    Secco, Danielle
    HLA, 2024, 103 (05)
  • [24] Allele-Specific Knockdown of Mutant Huntingtin Protein via Editing at Coding Region Single Nucleotide Polymorphism Heterozygosities
    Oikemus, Sarah R.
    Pfister, Edith L.
    Sapp, Ellen
    Chase, Kathryn O.
    Kennington, Lori A.
    Hudgens, Edward
    Miller, Rachael
    Zhu, Lihua Julie
    Chaudhary, Akanksh
    Mick, Eric O.
    Sena-Esteves, Miguel
    Wolfe, Scot A.
    DiFiglia, Marian
    Aronin, Neil
    Brodsky, Michael H.
    HUMAN GENE THERAPY, 2022, 33 (1-2) : 25 - 36
  • [25] Pre-Clinical Evaluation of Allele-Specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides
    Southwell, Amber L.
    Skotte, Niels H.
    Caron, Nicholas
    Kordasiewicz, Holly
    Oestergaard, Michael
    Doty, Crystal N.
    Villanueva, Erika B.
    Xie, Yuanyun
    Felczak, Boguslaw
    Freier, Susan M.
    Swayze, Eric E.
    Seth, Punit P.
    Bennet, C. Frank
    Hayden, Michael R.
    MOLECULAR THERAPY, 2015, 23 : S277 - S277
  • [26] Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
    Jiaxin Hu
    Masayuki Matsui
    Keith T Gagnon
    Jacob C Schwartz
    Sylvie Gabillet
    Khalil Arar
    Jun Wu
    Ilya Bezprozvanny
    David R Corey
    Nature Biotechnology, 2009, 27 : 478 - 484
  • [27] Molecular haplotyping of genetic markers 10 kb apart by allele-specific long-range PCR
    MichalatosBeloin, S
    Tishkoff, SA
    Bentley, KL
    Kidd, KK
    Ruano, G
    NUCLEIC ACIDS RESEARCH, 1996, 24 (23) : 4841 - 4843
  • [28] Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
    Hu, Jiaxin
    Matsui, Masayuki
    Gagnon, Keith T.
    Schwartz, Jacob C.
    Gabillet, Sylvie
    Arar, Khalil
    Wu, Jun
    Bezprozvanny, Ilya
    Corey, David R.
    NATURE BIOTECHNOLOGY, 2009, 27 (05) : 478 - 484
  • [29] Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders
    Christie, Kathleen A.
    Courtney, David G.
    DeDionisio, Larry A.
    Shern, Connie Chao
    De Majumdar, Shyamasree
    Mairs, Laura C.
    Nesbit, M. Andrew
    Moore, C. B. Tara
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Investigating allele-specific CRISPR/Cas9 gene editing in Best disease
    Butt, Zaynab
    Smith, Joe
    Fernandez, Ana Alonso-Carriazo
    Ramsden, Conor
    da Cruz, Lyndon
    Coffey, Peter
    Carr, Amanda-Jayne Francis
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)